Skip to main navigation Skip to search Skip to main content

Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials

  • Ioannis Parodis
  • , Julius Lindblom
  • , Roger A. Levy*
  • , Margherita Zen
  • , Nursen Cetrez
  • , Alvaro Gomez
  • , Shereen Oon
  • , Christine Henning
  • , Munther Khamashta
  • , Holly A. Quasny
  • , Deven Chauhan
  • , Anca Askanase
  • , Ronald van Vollenhoven
  • , Mandana Nikpour
    • *Corresponding author for this work
  • Karolinska Institutet
  • Örebro University
  • GlaxoSmithKline
  • University of Padua
  • St. Vincent's Hospital Melbourne
  • Medical Affairs
  • Columbia University
  • Amsterdam UMC - University of Amsterdam
  • The University of Sydney

Research output: Contribution to journal › Article › Academic › peer-review

119 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases